Educational Aims {#d29e233}
================

This chapter aims to give an understanding of:The clinical situations in which ventilation is applied in the newbornThe approach to initiation of ventilation, including choice of mode of ventilation and first settingsThe physiological considerations and clinical evidence for adjustment of ventilator settingsThe rationale for target ranges for tidal volume, oxygen saturation and carbon dioxide

Introduction {#Sec1}
============

Success in providing respiratory support to the neonate requires a clear understanding of the context in which it is being applied. Perhaps more than for any other age group, the array of different situations in which ventilation is applied to the newborn infant is extremely broad, with in each case different pathophysiological disturbances and often the need to use a specific approach to apply ventilation optimally. Table [42.1](#Tab1){ref-type="table"} provides a list of the more common situations in which conventional ventilation is used in the neonate and includes some considerations regarding ventilator settings for each situation. For each situation, a suggested mode of ventilation is indicated, along with target ranges for positive end-expiratory pressure (PEEP) and tidal volume (*V* ~T~). Further discussion of the physiological rationale and available evidence for ventilator settings is set out below.Table 42.1The context of ventilatory support in the neonateSituationExamplesPredominant pathophysiological disturbance(s)ModePEEP\**V* ~T~ range (mL/kg)Considerations regarding ventilator mode and settings*Apnoea*Preterm infant with apnoea of prematurityEx-preterm infant with respiratory syncytial virusPoor respiratory drive, physiological consequences of episodic apnoea (bradycardia and desaturation)SIMVLow--medium4--5Should only need low mandatory ventilator rate. Lungs often relatively compliant, but potential for overdistension and volutrauma if pressure settings too high*Surgery/postsurgery*General aspectsAny infant with a painful surgical incisionSuppression of respiratory drive due to sedation. Limitation of respiratory excursion due to pain(S)IMVMedium5--6Low tidal volumes (\< 5 mL/kg) may predispose to atelectasisMay not trigger effectively if heavily sedatedAbdominal surgeryTerm infant -- gastroschisis repairPreterm infant -- laparotomy for necrotising enterocolitisRaised intra-abdominal pressure and diaphragmatic splintingSIMV or ACMedium--high5--6High PEEP needed to maintain EELV and recruitmentWhere intra-abdominal pressure very high, may be poor response to conventional ventilation; HFOV or HFJV preferredThoracic surgeryTerm infant -- lobectomy for congenital lobar emphysemaPreterm infant -- ligation of persistent ductus arteriosusLung compliance alterations intra-operatively; post-operative risk of air leakSIMV or ACMedium4--5Changes in both PEEP and *V* ~T~ may be needed intra-operatively*Lung disease*Diffuse alveolar diseasePreterm infant with RDSPoor lung compliance, compliant chest wallACHigh4--5Recruitment using PEEP increments may be helpful. Short *T* ~I~ and fast rate well toleratedTerm or preterm infant with haemorrhagic pulmonary oedemaPoor lung complianceSIMV or ACHigh4--6Recruitment using PEEP increments and fixed tidal volume may be helpful. Longer *T* ~I~ needed to help recruitmentLocalised or heterogeneous diseasePreterm infant with nosocomial pneumoniaTerm infant with meconium aspiration syndromeAreas of low compliance with adjacent areas of relatively normal lungSIMV or SIMV + PSVMedium5--6Potential for overdistension of relatively normal lung regions. Fast ventilator rates may result in a *T* ~E~ that is too short for normal lung regions. Higher *V* ~T~ needed in meconium aspiration due to increased alveolar dead spaceInflammatory and/or fibrotic diseasePreterm infant with chronic lung diseaseRegions of low compliance and increased resistance, especially expiratory resistanceSIMV + PSV or ACMedium--high5--7Fast ventilator rates may result in a *T* ~E~ that is too short for the diseased lung regions with long expiratory time constants. Sufficient PEEP is needed to prevent expiratory flow limitation at low lung volumesPulmonary hypoplasiaPreterm infant born after early and prolonged rupture of membranesTerm infant with congenital diaphragmatic herniaLow lung compliance related to small total lung volume. Overdistension of lungs at standard ventilator pressuresSIMV or ACLow--medium3--5Hypoplastic lung is vulnerable to overdistension, stretch injury and high pulmonary vascular resistance. Avoid high *V* ~T~/PIP. Consider high-frequency ventilation if PIP \> 25 cm H~2~O, or if there is refractory hypoxic respiratory failureGas trapping/air leakPreterm infant with pulmonary interstitial emphysemaCompression of normal airspaces by interstitial gasSIMVMedium4--5Low PEEP approach may lead to persistent hypoxaemia and respiratory acidosis. High-frequency ventilation (especially HFJV) is preferablePneumothorax (after drainage)Continued leak of gas into the pleural spaceSIMV or ACMedium4--5Consider high-frequency ventilation (if available) where there is a torrential gas leakPulmonary insufficiency of prematurityExtremely preterm infant in room air shortly after birth, failing extubation due to inadequate respiratory effortGlobal immaturity of respiratory system, with low respiratory muscle capacityAC or SIMV + PSV for weaningMedium4--5Lungs become relatively compliant once atelectasis resolved, and there is potential for overdistension and volutrauma if pressure settings too high.Persistent pulmonary hypertensionPPHN with parenchymal lung diseaseReduced pulmonary blood flow secondary to increased pulmonary arteriolar tone, exacerbated by low alveolar pO~2~ and pHSIMV or ACMedium4--6*V* ~T~ and PEEP requirements depend on associated parenchymal diseasePPHN with normal lung parenchymaReduced pulmonary blood flow secondary to increased pulmonary arteriolar toneSIMV or ACLow4--5Avoid hyperventilation*Cardiac disease*Left to right shuntsPreterm infant -- patent ductus arteriosusTerm infant -- large ventricular septal defectDecreased lung compliance related to pulmonary engorgement and oedemaACHigh5--6Increasing CO~2~ can help limit blood flow to some degreeVulnerable pulmonary circulationPulmonary atresia with duct-dependent pulmonary circulationHypoplastic left heart syndrome, post-Norwood operationPulmonary blood flow highly variable and under the influence of intra-alveolar pressureSIMVLow--medium5--7Lung overdistension with high-pressure settings will restrict pulmonary blood flow. Manipulation of pCO~2~ can help to control pulmonary blood flow -- lower CO~2~ to promote blood flow, increase CO~2~ to restrict blood flow*Neuromuscular disease*Term infant with myotonic dystrophyLow FRC and *V* ~T~ secondary to compromised respiratory muscle functionAC or SIMV + PSVMedium4--6Appropriate to give mechanical support for each breath*Airway obstruction*Supra-glottic airway obstructionSevere Pierre Robin sequenceAlveolar hypoventilation, normal lung complianceSIMVLow--medium4--6Glottic/sub-glottic airway obstructionTerm infant with oesophageal atresia and tracheomalaciaAlveolar hypoventilation, expiratory prolongation and gas trappingSIMVLow--medium if obstruction relieved, high otherwise4--6Settings influenced by whether the obstruction can be relieved by positioning of the endotracheal tube tip beyond the point of maximal narrowing*PEEP* positive end-expiratory pressure, *V* ~T~ tidal volume, *SIMV* synchronised intermittent mandatory ventilation, *AC* assist/control, *EELV* end-expiratory lung volume, *HFOV* high-frequency oscillatory ventilation, *HFJV* high-frequency jet ventilation, *T* ~*I*~ inspiratory time, *T* ~*E*~ expiratory time, *PSV* pressure support ventilation\*PEEP levels: low = 4 cm H~2~O (preterm), 5 cm H~2~O (term); medium = 5--6 cm H~2~O (preterm), 6--8 cm H~2~O (term); high = 7--8 cm H~2~O (preterm), 9--12 cm H~2~O (term)

Choosing the Ventilator Mode {#Sec2}
============================

To a significant degree, the clinician's choice of ventilator modes is limited by the equipment available in his or her NICU. Although most modern ventilators are capable of providing the basic modes of synchronised (patient-triggered) ventilation, there are a variety of hybrid modes or combinations that may be unique to each manufacturer and device. For example, some ventilators make possible the combination of synchronised intermittent mandatory ventilation (SIMV) and pressure support ventilation (PSV), and other ventilators employ PSV as a stand-alone mode with a backup rate, similar to assist/control (AC) but flow rather than time cycled. PSV eliminates the inspiratory hold, making for better synchronisation and automatically adjusting the effective inspiratory time (*T* ~I~) as time constants change. However, this mode may not be appropriate in extremely small premature infants in the first few days of life, in whom respiratory time constants are so short that the actual *T* ~I~ may be less than 0.25 s. This duration of inspiration may be inadequate for gas mixing in the terminal air spaces and additionally may lead to excessively rapid respiratory rates.

Ventilators designed primarily for adult/paediatric patients but capable of also supporting neonates tend to have a greater variety of modes (some untested in newborn infants) and to offer volume-controlled ventilation. Unlike on the specialty neonatal ventilators, PSV on these devices does not have a backup rate and thus requires a reliable respiratory effort, not often present in preterm infants. However, when ventilating newborn infants, the clinician must be aware of the pitfalls of applying various modes to this unique population. The major limitation of volume-controlled ventilation is that the device only controls the volume delivered into the proximal (ventilator) end of the circuit, not the volume entering the patient's lungs. Because of compression of gas and stretching of the circuit, as well as leak around uncuffed endotracheal tubes (ETT), there is only a very indirect relationship between set and delivered *V* ~T~. For this reason, time-cycled, pressure-limited ventilation has been the standard ventilation mode in the NICU. There are several volume-targeted modes of pressure-limited ventilation with different operating principles and capabilities that more accurately control delivered *V* ~T~ in newborn infants. Some of these modalities have been studied in considerable detail and shown to reduce the incidence of hypocapnia, excessively large *V* ~T~, duration of mechanical ventilation and to decrease levels of pro-inflammatory cytokines (Keszler [@CR56]). Volume-targeted ventilation is discussed in detail elsewhere in this book. The more conventional modes are discussed below, and suggestions regarding the most appropriate modes for neonatal ventilation are incorporated in Table [42.1](#Tab1){ref-type="table"}.

Despite many years of daily use, no consensus has emerged regarding the relative merits of the commonly used modes of synchronised ventilation. Guidance from large prospective trials with important clinical outcomes, such as incidence of air leak, chronic lung disease or length of ventilation, is lacking. Short-term clinical trials have demonstrated less tachypnoea and less variable *V* ~T~ (Mrozek et al. [@CR68]), more rapid weaning from mechanical ventilation (Chan and Greenough [@CR18]; Dimitriou et al. [@CR28]) and smaller *V* ~T~ with smaller fluctuations in blood pressure (Hummler et al. [@CR52]) with AC, compared to SIMV. There are important physiological considerations suggesting that SIMV may not provide optimal support in very premature infants. SIMV supports a user-defined number of breaths synchronised with the infant's spontaneous respiratory effort. Spontaneous breaths in excess of the set rate are not supported, resulting in uneven tidal volume and high work of breathing during weaning. This is particularly important in extremely small and immature infants intubated with a narrow bore ETT (Fiastro et al. [@CR37]). The high airway resistance of the ETT, limited muscle strength and mechanical disadvantage of the infant's excessively compliant chest wall result in small, ineffective *V* ~T~. Small breaths that largely rebreathe dead space gas will contribute little to effective alveolar ventilation. To maintain adequate alveolar minute ventilation, relatively large *V* ~T~ is thus required with the limited number of mechanical inflations provided by the ventilator. In a group of ELBW infants in the recovery phase of respiratory distress syndrome (RDS) ventilated with SIMV, the *V* ~T~ of mechanical inflations was about 6 mL/kg with spontaneous *V* ~T~ of 2.5 mL/kg, very close to anatomical dead space (Osorio et al. [@CR74]). However, most clinicians continue to use SIMV, particularly during the weaning phase (Sharma and Greenough [@CR86]). This is based on the intuitive assumption that fewer mechanical inflations are less damaging and on the traditional thinking that the ventilator rate must be lowered before extubation. However, because lung injury is primarily caused by excessive *V* ~T~, irrespective of the pressure required to generate that *V* ~T~ (Dreyfuss and Saumon [@CR30]; Hernandez et al. [@CR49]; Dreyfuss and Saumon [@CR31]), the smaller *V* ~T~ used with AC (Hummler et al. [@CR52]) likely outweighs the faster rate. This concept is supported by the Oxford Region Controlled Trial of Artificial Ventilation study where a ventilator rate of 60 inflations per min compared to 20--40 was shown to result in less air leak with unsynchronised IMV (OCTAVE Study Group [@CR72]). Many clinicians also mistakenly believe that assisting every breath prevents respiratory muscle training. This concern reflects a poor understanding of the patient--ventilator interaction during synchronised ventilation. With synchronised ventilation, the *V* ~T~ is generated by the combined inspiratory effort of the patient (the baby pulling air in) and the positive pressure generated by the ventilator pushing air in. The resulting transpulmonary pressure, together with the compliance of the respiratory system, determines the *V* ~T~. Thus, as ventilator inflation pressure is decreased during weaning, the infant gradually assumes a greater proportion of the work of breathing and achieves respiratory muscle training. Ultimately, the ventilator pressure is decreased to the point when it only overcomes the added resistance of the ETT and circuit, at which point the infant should be extubated.

There is little difference between the modes during the acute phase of the disease when SIMV rate is relatively high. The differences become more meaningful during weaning, especially at rates \<20. The less intuitive weaning process with AC appears to be one of the reasons clinicians continue to employ SIMV during weaning from mechanical ventilation. Another reason is the anecdotal observation that sometimes infants become tachypnoeic with AC and may have mild hypocapnia. This tachypnoea may reflect the infant's response to low mean airway pressure (*P* ~AW~) during weaning -- shortening the expiratory time (*T* ~E~) serves to maintain lung volume at end expiration. Tachypnoea appears to be infrequent when decreasing peak inspiratory pressure (PIP) is balanced by higher PEEP to avoid loss of lung volume. Low rate SIMV, especially in small infants with 2.5-mm-diameter ETT, is likely to impair the weaning process. Some ventilators offer the option of supporting spontaneous breaths with pressure support ventilation. This will compensate for the problems associated with simple SIMV but becomes a more complex process requiring the clinician to select settings for both SIMV and the level of pressure support. Nonetheless, more rapid weaning when SIMV was combined with PSV compared to SIMV alone has been demonstrated (Reyes et al. [@CR79]). Based on these findings, it is recommended that when SIMV is used during the weaning process, PSV should be utilised to support spontaneous breathing. The alternate and less complicated approach is to use AC or PSV as a stand-alone mode to assist all spontaneous efforts and simply wean the inflations pressure, taking care to maintain adequate *P* ~AW~. This is most easily accomplished when using volume-targeted modes of ventilation discussed earlier in this book. Finally, the attributes of the particular ventilator may influence the choice of triggered modes. Many flow-triggered devices are susceptible to auto-triggering due to leak around the ETT. This is more problematic with AC than with SIMV, where the mechanical breath rate is limited. Devices that have a very effective leak-adapted trigger and breath termination algorithms, such as the Draeger Babylog, are virtually immune from this problem and thus facilitate the use of AC.

First Settings {#Sec3}
==============

This section focuses on the initial management of the ventilated infant following intubation. Overall rationale for, and evidence supporting, choice of ventilator settings in newborns is set out in Sect. [42.4](#Sec6){ref-type="sec"}.

After intubation, a period of ventilation using a portable ventilation device will usually be required until the endotracheal tube is secured, nasogastric tube inserted, and the baby positioned in readiness for ventilation. In preterm infants, bolus surfactant may also be given at this time. If the ventilation device does not allow delivery of PEEP, the infant should be connected to the ventilator as quickly as possible.

The initial ventilator settings should take into account the context in which ventilation is being applied to the neonate (Table [42.1](#Tab1){ref-type="table"}) and the apparent response to the pressure settings being used during ventilation with a portable device. There should be a stepwise approach to setting the ventilator at the time of initiation of mechanical ventilation (Table [42.2](#Tab2){ref-type="table"}), guided in part by a thorough clinical appraisal (Table [42.3](#Tab3){ref-type="table"}). PEEP should be considered first, with suggested PEEP levels for a range of different situations set out in Table [42.1](#Tab1){ref-type="table"}. The *T* ~I~ should be set at around 0.5 s for a term infant and 0.35 s for a preterm infant, and then further adjusted depending on the analysis of the flow--time curve, which can be displayed on most modern neonatal ventilators. For most applications of time-cycled pressure-limited ventilation, *T* ~I~ should be set long enough to allow complete or near-complete inflow of gas into the lung during inspiration. If the *T* ~I~ is too short, there may not be sufficient time for an adequate tidal volume to be delivered nor for alveolar recruitment to occur with each tidal inflation. Setting PIP should be guided by a visual appreciation of chest rise and preferably the measured *V* ~T~. Suggested target values for *V* ~T~ are set out in Table [42.1](#Tab1){ref-type="table"}. Finally, *T* ~E~ (and thus, respiratory rate) is adjusted, with the aim of producing sufficient minute ventilation to clear CO~2~ without causing dynamic hyperinflation related to inadvertent PEEP. An estimate of minute ventilation can be made using the product of measured *V* ~T~ and respiratory rate, with a value of 200--300 mL/kg/min usually being an adequate starting point before the first pCO~2~ reading is obtained. Note that this estimate of minute ventilation does not incorporate dead space volume, which is substantial in some infants, particularly those with hyperinflated lungs ("alveolar dead space"). Additionally, rapid shallow breathing leads to high dead space to *V* ~T~ ratio and reduced alveolar ventilation. Avoidance of inadvertent PEEP can be difficult when an infant has a rapid spontaneous breathing rate and each breath is being supported by the ventilator. Examination of the flow--time curve during expiration will reveal whether gas outflow is complete before the next inflation begins and thus whether dynamic hyperinflation is likely to occur. If so, further adjustment to the mode of ventilation, respiratory rate and even inspiratory time may be necessary, as discussed below.Table 42.2Stepwise approach to initial ventilator settingsThese parameters to be set in the order suggested PEEP -- set according to context (see Table [42.1](#Tab1){ref-type="table"}) and oxygen requirement *T* ~I~ -- sufficient to allow complete gas inflow to occur (and longer, if tidal recruitment needed) PIP -- sufficient to produce adequate chest movement (and *V* ~T~, when measured) *T* ~E~ (or ventilator rate)^a^ -- set so as to allow complete gas outflow to occur and, in combination with *V* ~T~, to produce adequate minute ventilation*PEEP* positive end-expiratory pressure, *T* ~*I*~ inspiratory time, *PIP* peak inflation pressure, *V* ~*T*~ tidal volume, *T* ~*E*~ expiratory time^a^In some ventilators, the rate is set directly, and in others it is determined by the combination of inspiratory and expiratory time Table 42.3Clinical evaluation after initiation of mechanical ventilation*Observation* Colour and circulation Infant's spontaneous respiratory rate Patient--ventilator interaction -- evidence of triggering/autocycling Chest rise and diaphragmatic excursion Work of breathing Gastric distension*Auscultation* Breath sounds to all lung areas Adventitial sounds Large airway sounds Heart sounds*Ventilation parameters* Delivered tidal volume Flow--time curve -- evidence of sufficient inspiratory and expiratory time

Assessment After Going onto the Ventilator {#Sec4}
------------------------------------------

A thorough clinical re-evaluation after initiation of ventilation is essential (Table [42.3](#Tab3){ref-type="table"}), with the expectation that further adjustments to ventilator settings may be necessary. Careful note of the rate of spontaneous ventilation, and the effectiveness of triggering, should be made as the infant recovers from the intubation and the effects of any sedative and muscle relaxant drugs used prior to it. The need for further sedation/analgesia should be assessed. Muscle relaxation is rarely indicated in the era of effective synchronised ventilation. Narcotic analgesia should be used judiciously; clinical trial evidence suggests morphine administration relieves pain in ventilated neonates but may increase the risk of adverse neurological outcomes (Anand et al. [@CR5]). If spontaneous breathing is to continue, the trigger sensitivity may need to be altered to optimise patient--ventilator interaction. In general, the trigger threshold should be as low as possible without causing autocycling, because higher trigger threshold is associated with higher work of breathing and longer trigger delay. An attempt should always be made to confirm whether "triggered" inflations are actually preceded by spontaneous respiratory effort or, alternatively, whether the ventilator is autocycling. The latter situation is more likely when there is a significant tube leak (despite "tube compensation") (Bernstein et al. [@CR10]), or with condensed water collecting in the ventilator tubing, and can lead to very significant hyperventilation particularly in AC mode.

Observation of the chest rise and abdominal motion will give some guide to the delivered *V* ~T~, although this is a clinical skill that requires some time to learn (Aufricht et al. [@CR8]), and may underestimate the actual *V* ~T~ (Schmolzer et al. [@CR84]). High residual work of breathing may reflect inadequate tidal volume or inadequate minute ventilation, and ventilator settings should be adjusted appropriately. In the immediate post-intubation period, respiratory system compliance may be transiently decreased due to gaseous abdominal distension, especially after prolonged face mask ventilation. Venting of the stomach with a tube should occur soon after intubation to overcome any impairment of respiratory system compliance related to gastric distension with gas (Heldt [@CR48]). Airway obstruction or ETT malposition should also be ruled out if the infant appears to be struggling.

Auscultation of the chest gives vital information in the intubated patient (Table [42.3](#Tab3){ref-type="table"}) and should be conducted thoroughly and carefully after mechanical ventilation has been initiated. The intensity and distribution of breath sounds within the thorax gives information about the nature of the respiratory pathology and the effectiveness of ventilation. Uneven breath sounds (lower intensity over left hemithorax) suggest the possibility of tube malposition with the tip in the right main bronchus. The presence of a large airway noise which abates when the tube is pulled out a small distance adds further support. Large airway noise (low-pitched inspiratory noise) can relate to a build-up of secretions in the intrathoracic conducting airways and may also be transmitted from the glottic level in the presence of an endotracheal tube leak. If caused by tube leak, the noise will be of similar intensity (or louder) on auscultation with the stethoscope applied over the forehead (due to its extrathoracic origin). Applying cricoid pressure to ablate the leak provides additional confirmation.

The final component of the initial clinical assessment after commencing ventilation is an analysis of available ventilator data. Observation should be made over a number of inflations of the delivered *V* ~T~ for a set PIP or, conversely, the PIP required to deliver a set *V* ~T~. If in a volume-targeted mode, the PIP limit may need to be increased if the desired *V* ~T~ is not being delivered. Analysis of the flow waveform will allow refinements of *T* ~I~ and expiratory time (*T* ~E~).

After intubation and commencement of mechanical ventilation, a chest X-ray should always be performed to confirm the position of the endotracheal tube, to assess the state of the lung parenchyma and to gain an appreciation of the degree of lung inflation. Given that chest X-rays are taken at peak inflation, the degree of lung inflation will be a reflection of end-inspiratory lung volume (EELV plus *V* ~T~), and thus does not help significantly in titrating PEEP. For this reason, some investigators have chosen to perform chest X-rays at end expiration (Pohlandt et al. [@CR76]), but this is not currently a widespread practice.

Monitoring and Documentation During Mechanical Ventilation {#Sec5}
----------------------------------------------------------

With the need for mechanical ventilation comes the need for intensive monitoring and careful charting of physiological and ventilatory parameters. All mechanically ventilated infants should have, at the very least, cardiorespiratory monitoring, continuous measurement of oxygen saturation (SpO~2~) via a transcutaneous pulse oximetry probe and temperature monitoring (Table [42.4](#Tab4){ref-type="table"}). An intra-arterial catheter to continuously monitor blood pressure and allow periodic arterial blood gas sampling is essential in the unstable and critically ill infant and highly desirable in any infant requiring mechanical ventilation. A continuous estimate of pCO~2~ derived from transcutaneous monitoring or end-tidal gas sampling is also valuable, whether or not an arterial line is in place. Because ET CO~2~ monitoring adds significantly to the instrumental dead space and is often inaccurate in small infants whose rapid respiratory rates do not allow an end-tidal plateau to be reached, transcutaneous monitoring is to be preferred in most ventilated neonates.Table 42.4Monitoring of the ventilated infant*Physiological monitoring*Essential Cardiorespiratory monitoring (numeric display of heart rate and respiratory rate, with preferably a real-time display of 3-lead ECG wave and respiratory impedance tracing) Transcutaneous SpO~2~ (numeric display with preferably a plethysmographic SpO~2~ tracing) TemperatureDesirable Intra-arterial catheter placement for continuous blood pressure monitoring and intermittent arterial blood gas sampling Transcutaneous pCO~2~ (+/− pO~2~) End-tidal CO~2~ (infants beyond term)*Ventilation parameters to be monitored and recorded*Essential Delivered ventilator pressures (PEEP, PIP and *P* ~AW~) *T* ~I~ Respiratory rate (mechanically assisted and total) *V* ~T~ (breath by breath, preferably the expired *V* ~T~ measured at the airway opening) %leak (difference between inspired and expired *V* ~T~, expressed as a percentage of the inspired *V* ~T~) Humidifier temperatureDesirable Ventilator waveforms (time scalars of pressure and flow) Compliance and resistance measurements Tidal pressure--volume curves*PEEP* positive end-expiratory pressure, *PIP* peak inspiratory pressure, *P* ~*AW*~ mean airway pressure, *T* ~*I*~ inspiratory time, *V* ~*T*~ tidal volume

Ventilation parameters that should be monitored and recorded include ventilator pressures and timing and the total breath number and number of mechanically assisted breaths per minute (Table [42.4](#Tab4){ref-type="table"}). The delivered *V* ~T~ (and the target *V* ~T~, if set) should be noted, along with the proportion of leak. To be accurate, *V* ~T~ must be measured at the airway opening, not at the ventilator end of the circuit. Whilst some devices offer a compliance compensation feature that corrects for the loss of *V* ~T~ in the circuit, this feature does not function well in the presence of ETT leak. The humidifier temperature should be regularly checked and recorded. Most modern ventilators also provide continuous display of waveforms and/or tidal ventilation loops, and these, along with breath-by-breath compliance and resistance measurements, can be very helpful in fine-tuning ventilator settings, as described in this and other chapters in this text.

Ventilator Settings and Strategies: Pathophysiological Rationale, Meta-analytic Evidence and Therapeutic End Points {#Sec6}
===================================================================================================================

Manipulating End-Expiratory Lung Volume {#Sec7}
---------------------------------------

Physiological first principles, and a large body of experimental and clinical evidence, point to the importance of manipulating EELV during mechanical ventilation of the diseased lung. It has become clear that to apply ventilation optimally requires a well-recruited lung with adequate end-expiratory volume (Rimensberger [@CR81]; Clark et al. [@CR20]). Such an approach is dependent on the application of sufficient PEEP, and the physiological considerations that guide PEEP setting are discussed in this section.

Clinical and experimental data point to a clear relationship between PEEP and EELV and, thus, oxygenation. Changes in other ventilator settings may, however, potentially lead to alterations in EELV. A long-held belief was that an increase in *P* ~AW~ by alteration of any combination of ventilator settings would have a similar impact on oxygenation and thus that there should be an optimal *P* ~AW~ at which to apply ventilation (Boros et al. [@CR14]). It is now becoming accepted that the components that make up the *P* ~AW~ (PIP, PEEP, *T* ~I~, rate and gas flow) should be considered separately. As stated by Monkman and Kirpalani: "In retrospect, the simplifying but reductionist elegance that focused upon a single unitary number \[P~AW~\] may have misled the field. (Monkman and Kirpalani [@CR67])"

Thus, an improvement in oxygenation after a PEEP increase should not be viewed as having occurred simply because the *P* ~AW~ is higher but rather because EELV has increased and $\documentclass[12pt]{minimal}
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\end{document}$ matching has improved. Despite also producing *P* ~AW~ changes, alteration in other ventilator parameters does not have the same effect on EELV (Fig. [42.1](#Fig1){ref-type="fig"}) (Thome et al. [@CR98]) nor on oxygenation (Stewart et al. [@CR92]). The inextricable linkage between PEEP, EELV and oxygenation dictates that it is PEEP that is the first, and arguably the most important, ventilatory parameter to be considered in the continuing management of the ventilated neonate. Fig. 42.1Effect of ventilation changes on end-expiratory lung volume. Changes in end-expiratory lung volume (EELV, denoted as functional residual capacity, FRC) during programmed manipulation of ventilator settings in a ventilated infant. EELV is seen to reduce with stepwise reductions in positive end-expiratory pressure (PEEP) and thus mean airway pressure (*P* ~AW~, denoted as MAP) during the first 30 min. At minute 34, inspiratory time is lengthened from 0.3 to 0.6 s, leading to an increase in *P* ~AW~, but no significant change in EELV. Conversely, when PEEP is increased (minute 52), there is a substantial improvement in EELV (Reproduced from Thome et al. ([@CR98]) with permission)

An important difficulty in manipulating EELV in the ventilated subject is that the available methods to measure EELV at the bedside are imprecise and in some cases impractical (Dargaville and Rimensberger [@CR24]). Whole-body plethysmography (Stocks et al. [@CR93]) and gas dilution (Sivan et al. [@CR89]; Vilstrup et al. [@CR106]), both of which give absolute values for EELV, are not appropriate for repeated measurements in a clinical setting. Other methods, including respiratory inductance plethysmography (Adams [@CR1]; Emeriaud et al. [@CR34]), fibre-optic plethysmography (Davis et al. [@CR26]) and electrical impedance tomography (Frerichs et al. [@CR38]), allow measurement not of absolute volume but of change in EELV relative to a baseline condition, and only with prior calibration can a gas volume change in mL be derived. Despite these limitations, a great deal of information has been obtained from experimental studies in which EELV has been measured, either at the bedside or in the laboratory, as alterations in PEEP have been made. The key findings of this work are set out below. This knowledge can be used by clinicians to set and titrate PEEP in ventilated subjects, aided by indirect measures of EELV, in particular oxygenation and tidal breath compliance.

### Relationships Between PEEP, EELV and Recruitment {#Sec8}

An understanding of what can potentially be achieved through manipulation of lung volume using PEEP comes from firstly examining the changes in EELV and recruitment during stepwise PEEP manoeuvres. Such information is derived from lung modelling, studies in experimental animals and in humans with lung disease. An example is shown in Fig. [42.2](#Fig2){ref-type="fig"}. With stepwise PEEP increments and a constant inflating pressure (PIP--PEEP), a surfactant-depleted lung starting at residual volume follows the path of the inflation limb of the pressure--volume (PV) relationship (Fig. [42.2](#Fig2){ref-type="fig"}), with an improvement in tidal breath compliance as more non-aerated lung units are recruited, followed by a fall in compliance as more lung units become overdistended near total lung capacity. During PEEP decrements (Fig. [42.2](#Fig2){ref-type="fig"}), the property of hysteresis is demonstrated with a different PV trajectory than during PEEP increments, following a path closer to the deflation limb of the PV relationship. There is preservation of recruitment through a large proportion of this trajectory, and the open tidal ventilation loops reflect the marked improvement in compliance during PEEP decrements, as has been predicted by lung modelling (Hickling [@CR50]). At the point of maximal curvature of the deflation limb ("closing pressure"), the lung is still well inflated, recruitment is largely preserved and tidal ventilation at this point is associated with minimal overdistension and a peak in compliance. This is the point of "optimal PEEP", at which the lung is ventilated with the best possible oxygenation and compliance and with the least possible pressure (Rimensberger et al. [@CR82]). Additional advantages of optimising PEEP in this way are shown in Table [42.5](#Tab5){ref-type="table"}. In the experimental animal with recruitable lungs, PEEP set in relation to the point of maximal curvature of the deflation limb is often at or below the PEEP value predicted from the lower inflection point of the inflation limb (Rimensberger et al. [@CR82]). Fig. 42.2Stepwise vital capacity manoeuvre in the injured lung. Pressure--volume curve during a stepwise vital capacity manoeuvre using positive end-expiratory pressure (PEEP) increments and decrements in a mechanically ventilated 2.1 kg piglet after repeated saline lavage. Each PEEP level was held for 15 s. Inflating pressure (peak inspiratory pressure -- PEEP) remained at 10 cm H~2~O throughout. *Y*-axis shows lung volume measured by respiratory inductance plethysmography and scaled to total lung capacity (TLC). Complete tracing is shown in *grey* and the final breath at each PEEP level in *black*, and the tidal breath compliance (mL/cm H~2~O/kg) for each of the final breaths is indicated in *italics* (Data derived from same experimental series as reference (Dargaville et al. [@CR25])) Table 42.5The benefits of positive end-expiratory pressure (PEEP) optimisation in the diseased lungMaintenance of lung recruitmentDefence against absorption atelectasis in high FiO~2~Improved lung compliance and thus a reduction in peak inflation pressure to achieve the same tidal volumeBetter oxygenation and a reduction in FiO~2~More efficient CO~2~ removalMore even distribution of ventilationPreservation of surfactantReduction in lung injury

Finding optimal PEEP as described above is not difficult in experimental animals, as long as the lung is recruitable and can withstand brief inflation to total lung capacity. The technique has also been applied to adult subjects with acute respiratory distress syndrome (Amato et al. [@CR4]; Suarez-Sipmann and Bohm [@CR95]), allowing confirmation of many of the physiological features noted in the laboratory. A limiting factor is that if the lung has few recruitable units, there will be minimal hysteresis and the PEEP at the point of maximal curvature of the deflation limb may actually be higher than the PEEP at the lower inflection point on the inflation limb, with minimal benefit in compliance, and the risk of overdistension with each tidal breath (Albaiceta et al. [@CR2]).

In mechanically ventilated newborn infants, there have been few attempts to find optimal PEEP using stepwise increments and decrements as described above. The PV relationship of the lung has, however, been mapped in ventilated infants on high-frequency oscillatory ventilation (HFOV), allowing definition of hysteresis and a point of maximal curvature (closing pressure) on the deflation limb (Tingay et al. [@CR101]). Similar PV tracing during HFOV, using oxygenation as in indicator of lung volume, is routinely used in some institutions to identify optimal *P* ~AW~ (De Jaegere et al. [@CR27]). The deflation limb of the PV relationship has also been traced in preterm infants using a quasistatic technique performed over a maximum of 10 s (Vilstrup et al. [@CR107]). A point of maximal curvature appears to be identifiable in each recording, but in this early study, no attempt was made to use this landmark for PEEP setting. In parallel with adult studies, there has been some attempt to set PEEP in newborn infants based on the shape of the inspiratory PV curve, traced over 30 s after a 5 s disconnection to ambient pressure (Mathe et al. [@CR65]). An inflection point was identifiable in each infant, with greater concavity in those with more severe disease (indicating potential for recruitment). Change in the position of the inflection point, and the concavity of the inflation limb, was noted with resolution of disease (Fig. [42.3](#Fig3){ref-type="fig"}). Setting PEEP by this method improved oxygenation in infants at the height of disease, but not those in the recovery phase (Mathe et al. [@CR65]). Fig. 42.3Inflation limb of the pressure--volume relationship in an infant with respiratory distress syndrome. Sequential inflation limb pressure--volume curves from a newborn with respiratory distress syndrome recorded at 6, 24, and 48 h. *X*-axis, applied pressure; *Y*-axis, volume of insufflated oxygen. The initial slope (*a*) and slope in the linear portion of the pressure--volume curve (*b*) are shown at 6 h. *Black arrows* and point *P* indicate the lower inflection point, at which positive end-expiratory pressure was then set. Note the shift in position of this point with improvement in lung function (Redrawn from Mathe et al. ([@CR65]), with permission)

With the exception of these more penetrating studies, the investigation of PEEP and PEEP setting in ventilated neonates has been limited to studies of short-lived PEEP adjustments, in some cases with stepwise PEEP increments analogous to the titration of CPAP described in the very earliest reports of this therapy (Gregory et al. [@CR46]). Increases in PEEP universally lead to an increase in EELV (Thome et al. [@CR98]; Dinger et al. [@CR29]; Bose et al. [@CR15]) and an improvement in oxygenation (Stewart et al. [@CR92]; Dinger et al. [@CR29]; Bose et al. [@CR15]). In the diseased lung, the oxygenation response to increasing EELV is related to both decreased venoarterial shunting due to recruitment of non-aerated lung units and improvement of $\documentclass[12pt]{minimal}
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\end{document}$ matching with better gas aeration. The potential for PEEP to induce change in EELV in the ventilated neonate is significantly greater than for isolated changes in PIP or *T* ~I~ (Thome et al. [@CR98]). PEEP increases were most usually associated with a fall in tidal compliance suggesting overdistension (Dinger et al. [@CR29]; Alegria et al. [@CR3]). Infants with more severe lung disease may, however, demonstrate an improvement in compliance with PEEP increments indicating lung recruitment (Dinger et al. [@CR29]). The level of applied PEEP also has the potential to impact upon cardiac function, but it is clear that the adverse effects of PEEP on cardiac output are much more prominent in the normal lung (Holzman and Scarpelli [@CR51]). This relates to the transmission of intra-alveolar pressure to the pleural and mediastinal compartment, which is substantially greater in a recruited lung. Indeed, one study in the pre-surfactant era used rise in pleural pressure (as indicated by oesophageal pressure) to indicate the point at which lung recruitment had occurred during PEEP increments (Bonta et al. [@CR13]).

The findings of these studies are heavily influenced by the severity of lung disease in the subjects under study and the starting point and span of PEEP settings used. There has also been considerable reluctance to keep the driving pressure constant with PEEP adjustments, in part related to a misconception that PEEP by itself produces lung recruitment. Recruitment is an inspiratory phenomenon; the value of PEEP is in maintaining recruitment of open lung units at end expiration (Gattinoni et al. [@CR41]). None of the PEEP-titration studies in neonates have until recently emulated the "open lung" concept of lung recruitment followed by titration of PEEP using small pressure decrements (Suarez-Sipmann and Bohm [@CR95]; Lachmann [@CR60]). The only study designed to maintain stable pressure amplitude during PEEP increments investigated the effect of a lung recruitment maneuver (LRM) with incremental PEEP adjustments in infants with mean GA of 25 wk ventilated for RDS with AC+VG in a small randomized trial (Lista et al. [@CR62]). LRM consisted of 0.2 cm H~2~O increments in PEEP every 5 minutes, until FiO~2~ reached 0.25, followed by reduction of PEEP until oxygenation began to deteriorate. If FiO2 rose, PEEP was increased again to re-recruit the lung and then reduced again to situate the lungs on the deflation limb of the pressure/volume curve. Initial FiO2 was 56 ± 24 versus 52 ± 21, in the two groups. The full LRM lasted for 61 ± 18 minutes. The infants appeared to have only mild lung disease, with maximum PEEP reaching only 6.1 ± 0.3 cm H2O. LRM lead to faster weaning of FiO2 (94 ± 24 versus 435 ± 221 minutes; p = 0.000) and shorter O2 dependency (29 ± 12 versus 45 ± 17 days; p = 0.04). No adverse events and no differences in the outcomes were observed. Though limited by the modest severity of illness and small sample size, the study suggests that LRM with incremental PEEP adjustments is feasible during conventional ventilation.

### Guiding Principles for PEEP Setting in the Neonate {#Sec9}

There is no universal PEEP setting that is correct for all lung diseases, or even for one disease, or even for one individual through the course of their disease. Units that choose to mandate a PEEP level for reasons of simplicity or the need to protocolise ventilator settings are missing opportunities to manage respiratory failure optimally and according to sound physiological reasoning. Suggested ranges for PEEP are given in Table [42.1](#Tab1){ref-type="table"}; these should be considered in the light of the individual circumstances, with further adjustment according to the physiological response and the course of the disease. The PEEP setting should be re-evaluated whenever there is an alteration to pulmonary mechanics, for example, after surfactant administration (Goldsmith et al. [@CR44]).Unquestionably, very low PEEP (and zero PEEP) is inappropriate in the diseased lung (Monkman and Kirpalani [@CR67]), predisposing to low EELV, poor oxygenation, impaired pulmonary mechanics, greater turnover of surfactant and a risk of greater lung injury.Conversely, a PEEP level that is set too high for too long leads to overdistension of the lung, impairment of venous return and cardiac output and predisposition to pneumothorax.PEEP is not, of itself, a recruitment tool, and PEEP increments will not recruit the lung optimally without an adequate inflating pressure (PIP-PEEP) to reinflate non-aerated lung units. Once the lung is recruited, the PEEP (and PIP) must then be turned down.PEEP is effective in maintaining lung volume in circumstances predisposing to atelectasis, for example, during anaesthesia (Easa et al. [@CR33]) and/or after administration of muscle relaxants (von Ungern-Sternberg et al. [@CR108]). PEEP also helps to minimise absorption atelectasis associated with ventilation using 100 % oxygen (von Ungern-Sternberg et al. [@CR109]).

Inspiratory Time {#Sec10}
----------------

As described elsewhere in this text, the respiratory time constants that determine how rapidly lung volume re-equilibrates after a pressure change are determined by the compliance and resistance of the respiratory system (Bancalari [@CR9]). Infants with poorly compliant lungs secondary to RDS have very short time constants and thus require only a very short *T* ~I~ for equilibration to occur (as low as 0.15 s). This may, however, be insufficient time for tidal recruitment to occur during the inspiratory phase. Setting *T* ~I~ in the diseased lung must therefore find a balance between the wish to minimise the duration of plateau pressure at peak inflation and the need to provide adequate time for the recruiting effect of the pressure plateau.

Early ventilation strategies in ventilated neonates evolved to the use of a long *T* ~I~, in part because of the lack of PEEP, and the observation that longer *T* ~I~ and slower ventilator rates improved oxygenation in infants with RDS (Reynolds [@CR80]). With further, and more probing, clinical observations, it became clear that this pattern of ventilation was contrary to the spontaneous respiratory efforts of a preterm infant (South and Morley [@CR90]), unless muscle-relaxed. Clinical trials comparing long *T* ~I~ (0.66--1.0 s) with short *T* ~I~ (0.33--0.5 s) subsequently demonstrated an advantage in the shorter *T* ~I~ group, including a slight reduction in mortality and a clear decrease in the risk of air leak, particularly in infants with RDS (OCTAVE Study Group [@CR72]; Kamlin and Davis [@CR54]).

With the advent of synchronised ventilation has come a further imperative to match the ventilator *T* ~I~ to that of the infant. Inappropriately long set *T* ~I~ may lead to dyssynchrony, with the infant exhaling against the ventilator inflation pressure. Conversely if *T* ~I~ is too short (or lung volume loss too rapid), the infant may interrupt expiration with a further inspiratory effort during the ventilator expiratory cycle (McCallion et al. [@CR66]). From the suggested first *T* ~I~ settings (0.5 s in the term infant, 0.35 s in the preterm infant, see above), adjustments should be made based on the appearance of the flow waveform. *T* ~I~ should be prolonged if there is clearly insufficient time for flow to enter the lung. Shortening of the *T* ~I~ should be considered if there is a prolonged period of zero flow with an inflation pressure plateau; a suggested maximum for this period is one-third of the total inflation time. Recommended ranges for within which to set *T* ~I~ in the ventilated newborn are 0.25--0.4 s in preterm infants and 0.4--0.6 s in those at full term.

An alternative to making manual adjustments to *T* ~I~ is to use a flow-cycled mode with expiratory triggering (PSV) (Scopesi et al. [@CR85]). This mode is not recommended in the diseased lung prone to atelectasis (Keszler [@CR56]) but may be a sensible alternative during the weaning phase. If there is the option to adjust the percentage of peak inspired flow at which inflation terminates (termination sensitivity), a value no higher than 10 % is recommended.

Choosing the Appropriate Tidal Volume {#Sec11}
-------------------------------------

Since its inception, for a variety of reasons neonatal ventilation has largely been conducted using pressure-limited ventilatory modes. This remains so up until the present day (van Kaam et al. [@CR105]). Until recently, it has been difficult to measure tidal volumes, but the latest generation of neonatal ventilators allows accurate measurement of *V* ~T~, including expired *V* ~T~ measured at the airway opening. Monitoring and recording of *V* ~T~ is now routine in most neonatal intensive care units (van Kaam et al. [@CR105]), and with the availability of volume-targeted modes or volume-controlled ventilation, there has been a shift of focus away from the PIP applied and towards the *V* ~T~ that results. Suggested *V* ~T~ settings for neonatal ventilation are shown in Table [42.1](#Tab1){ref-type="table"}, and the physiological rationale and clinical evidence in relation to setting or targeting *V* ~T~ are set out below.

### Physiological Rationale for Targeting Tidal Volume {#Sec12}

Even in the normal lung, tidal ventilation is important not only for gas exchange but also for maintaining lung recruitment, with very low and/or monotonous *V* ~T~ contributing to atelectasis (Suki et al. [@CR96]; Mutch et al. [@CR70]). For the lung compromised by immaturity, disease or both, maintenance of an adequate *V* ~T~ during conventional ventilation is of paramount importance. There is compelling evidence for the need to monitor, target and limit tidal volumes in the ventilated neonate, with the clear message that both high and low *V* ~T~ settings can be dangerous (Keszler [@CR57]).

By virtue of the resultant stretch injury, ventilation with excessive *V* ~T~ in the neonate has the potential to cause long-standing damage. The combination of immature lung architecture and a highly compliant chest wall renders the newborn lung, and especially the preterm lung, uniquely vulnerable to overdistension and stretch injury (Clark et al. [@CR20]). Laboratory investigations have highlighted the danger of ventilation with high tidal volumes (Dreyfuss and Saumon [@CR31]; Dreyfuss et al. [@CR32]) with even a few large tidal inflations causing extensive lung injury in the immature lung (Bjorklund et al. [@CR11]). It is also clear that the severity and distribution of injury in this setting depend not only on the magnitude of *V* ~T~ but also on the state of the lung at end expiration, including the degree of recruitment and residual aeration of lung units (Clark et al. [@CR20]; Chiumello et al. [@CR19]). Application of high *V* ~T~ to an atelectatic lung causes significant alveolar injury maximal in the nondependent regions, i.e. those areas that remain expanded at end expiration (Tsuchida et al. [@CR102]). Prior reversal of atelectasis by surfactant treatment substantially attenuates the lung injury related to high *V* ~T~ in the preterm lung (Wada et al. [@CR110]), presumably because the gas delivered with each inflation is more evenly distributed, with less resultant regional overdistension (Dargaville et al. [@CR25]).

Clinical studies in ventilated newborn infants support a role for high *V* ~T~ in the pathogenesis of lung injury, although the evidence is largely circumstantial. Early clinical trials of rapid versus slow respiratory rates by necessity involved ventilation with different levels of *V* ~T~ to achieve similar minute ventilation, although the actual *V* ~T~ was not measured. In comparison to ventilation of infants with RDS with rates of at least 60/min, ventilation at slow rates of 30--40/min (and therefore higher *V* ~T~) was associated with a marked increase in pulmonary interstitial emphysema (Pohlandt et al. [@CR76]) and pneumothorax (OCTAVE Study Group [@CR72]). Other markers of over-ventilation in early life, such as hypocapnia, are known to increase the risk for the development of chronic lung disease (Garland et al. [@CR40]; Kraybill et al. [@CR59]), with one putative mechanism being volutrauma related to high *V* ~T~ (Rimensberger [@CR81]).

Whilst acknowledging the pivotal role of volutrauma in the development of ventilator-induced injury, it must be recognised that ventilation at inappropriately low *V* ~T~ also has consequences, both in the short and long term. Ventilation of the atelectatic lung at relatively low *V* ~T~ is associated with insufficient alveolar recruitment and EELV, poor gas exchange (Probyn et al. [@CR77]) and considerable lung injury (Muscedere et al. [@CR69]), with a predilection for the small airways. If, and only if, the lung is adequately recruited can the benefits of "gentle ventilation" with relatively small tidal volumes be realised. The combination of an "open lung" (Lachmann [@CR60]) and low *V* ~T~ provides adequate gas exchange and markedly reduces the risk of lung injury during mechanical ventilation (Rimensberger [@CR81]; Rimensberger et al. [@CR82], [@CR83]; van Kaam et al. [@CR104]). Studies of this approach in ventilated adults with acute respiratory distress syndrome have shown reduced mortality and more rapid weaning from ventilation (Amato et al. [@CR4]; ARDS Network [@CR71]). Controlled clinical trials of an open lung approach have yet to be conducted in ventilated newborns (van Kaam and Rimensberger [@CR103]).

### What Is the Safe Upper Limit of *V*~T~ in the Ventilated Neonate? {#Sec13}

In parallel with studies in adults showing the benefit of a *V* ~T~ of 6 mL/kg over a *V* ~T~ of 12 mL/kg (ARDS Network [@CR71]), limiting tidal volume to \<10 mL/kg in ventilated newborns seems appropriate, and most neonates are now ventilated with a *V* ~T~ of between 4 and 7 mL/kg (van Kaam et al. [@CR105]). Given the vulnerability of the preterm lung in the early days of life, an upper acceptable limit of 6--7 mL/kg is suggested in infants less than 32 weeks. There are particular circumstances in which a *V* ~T~ as low as 5 mL/kg may still induce injury. Infants with diaphragmatic hernia have immature and underdeveloped lungs which are exquisitely sensitive to volutrauma and by virtue of the reduced total lung capacity tend to respire with *V* ~T~ values less than 5 mL/kg (Te Pas et al. [@CR97]). For these infants the safe upper limit for *V* ~T~ may be below 5 mL/kg. Similar considerations apply for neonates with pulmonary hypoplasia from other causes, including preterm infants born after early and prolonged rupture of membranes.

### What Is the Safe Lower Limit of *V*~T~ in the Ventilated Neonate? {#Sec14}

Many preterm infants on synchronised ventilation using AC mode supporting every detected patient effort can achieve adequate gas exchange with *V* ~T~ values as low as 3--3.5 mL/kg (Scopesi et al. [@CR85]). The concern is that such low values of *V* ~T~ may over time be insufficient to maintain alveolar recruitment, in particular when low PEEP settings are used (Keszler [@CR55]). A clinical trial comparing *V* ~T~ targets of 3 and 5 mL/kg found the lower value to be associated with an increase in pro-inflammatory cytokines in bronchoalveolar lavage fluid (Castoldi et al. [@CR62]). *V* ~T~ targets below 5 mL/kg may be inappropriate in chronically ventilated preterm infants, in whom the *V* ~T~ required to maintain normocapnia was noted to increase to 6 mL/kg by the third week of ventilation (Keszler et al. [@CR57]). Additionally, there is a small but significant effect of the fixed instrumental dead space of the flow sensor necessary to measure VT. This additional dead space becomes proportionally larger in the smallest infants, resulting in the need for tidal volume of about 6 ml/kg to maintain normocapnia in infants around 500g, compared to larger preterm infants (Nassabeh-Montazami [@CR120]).

Respiratory Rate {#Sec15}
----------------

Selection of respiratory rate is a function of the mode of ventilation (SIMV vs AC, ±volume targeting) as well as the clinical scenario and degree of compromise of CO~2~ clearance. Some of the pioneering work on neonatal ventilation arrived at low ventilator rates and long *T* ~I~ as an appropriate strategy for neonatal ventilation. The technical limitations of the ventilators used, including the inability to directly provide PEEP, influenced this choice. Several clinical trials have found rapid respiratory rates (≥60/min), along with shorter *T* ~I~, to be less injurious to the lung than slower rates (OCTAVE Study Group [@CR72]; Pohlandt et al. [@CR76]). Additionally the use of a rapid ventilator rate allows more opportunity for synchrony given the rapid respiratory rate and short *T* ~I~ of most infants with lung disease (South and Morley [@CR91]). Suggestions for setting of respiratory rate are shown in Table [42.6](#Tab6){ref-type="table"}.Table 42.6Setting respiratory rateModeGestationContextSuggested set ventilator rate (inflations per minute)CommentsSIMV (or IMV if muscle-relaxed)TermHeight of disease40 (30--50)^a^Consider adding pressure support if there is high work of breathing with unassisted breathsWeaningReduce in decrements of 5--10PretermHeight of disease60 (40--80)^a^Consider changing to AC mode if there is high work of breathing with unassisted breathsWeaningReduce in decrements of 5Assist/controlTermHeight of diseaseBackup rate 30--40Ensure as many inflations as possible are triggeredWeaningBackup rate to remain below spontaneous breathing ratePretermHeight of diseaseBackup rate 40--60Ensure as many inflations as possible are triggeredWeaningBackup rate to remain below spontaneous breathing rate*SIMV* synchronised intermittent mandatory ventilation, *AC* assist/control^a^Starting point (range)

The combination of a rapid ventilator rate and a relatively long *T* ~I~ may lead to dynamic hyperinflation related to the development of inadvertent PEEP (Simbruner [@CR88]). Whilst some investigators have looked upon this as a way to improve lung recruitment, physiological first principles and experimental evidence would suggest that it is better to apply sufficient PEEP at the airway opening rather than rely on the generation of an unknown and variable amount of inadvertent PEEP to improve lung volume (Yanos et al. [@CR112]). Avoidance of dynamic hyperinflation is thus an important goal of neonatal ventilation, in particular in the context of an increased resistance to airflow. The flow waveform should be examined to ensure there is sufficient expiratory time for complete exhalation. A more definitive test for measurement of inadvertent PEEP has been described, which involves insertion of a T-piece in the ventilator circuit, brief interruption of ventilation by clamping and measurement of equilibrium pressure distal to the clamp (Simbruner [@CR88]). If there is suspicion of incomplete exhalation, available options to prolong expiratory time include (a) reduction of ventilator rate with *T* ~I~ kept constant or (b) shortening of *T* ~I~, if appropriate, whilst keeping ventilator rate constant. A combination of both of these may be the best solution.

Fractional Inspired Oxygen Concentration {#Sec16}
----------------------------------------

Oxygen was first administered to newborns within 6 years of its discovery in 1774, and its administration to the premature neonate has continued in various forms thereafter (Silverman [@CR87]). Use of "liberal" oxygen therapy, with an FiO~2~ above 0.5, first became widespread in preterm infants in the late 1940s, and its impact on the developing retinal vasculature was soon apparent in the form of a large number of infants (more than 10,000) blinded by retinopathy of prematurity (Silverman [@CR87]; Askie et al. [@CR7]). In the aftermath of this disaster of iatrogenesis, there was the recognition of the need to restrict oxygen therapy (Askie et al. [@CR7]), with measurement of both the FiO~2~ and the oxygenation response of the infant now considered essential. Unrestricted and/or inadequately regulated oxygen therapy, and the retinopathy following from it, is now a significant concern in developing and newly industrialised countries (Gilbert [@CR42]; Maida et al. [@CR63]), and a "third epidemic" of retinopathy has emerged in these nations coincident with the increase in preterm survivors (Gilbert [@CR42]; Maida et al. [@CR63]).

Notwithstanding the above, titration of FiO~2~ remains arguably the most neglected and least precise element of neonatal ventilation. Indwelling arterial oxygen sensors are no longer in use, and pO~2~ readings in blood taken from an arterial line give only a snapshot in time. For this reason, moment by moment adjustments in FiO~2~ are usually made on the basis of SpO~2~ readings, and it is clear that many infants, in particular preterm infants, spend considerable amounts of time with SpO~2~ readings (and therefore PaO~2~ levels) outside the desired or target range (Hagadorn et al. [@CR47]; Laptook et al. [@CR61]; Claure et al. [@CR21]). Given the shortages of nursing personnel in many neonatal units, very significant changes in SpO~2~ may go unnoticed and uncorrected for some time, putting a patient at risk of the effects of hypoxia or hyperoxia (Claure et al. [@CR21]; Bolivar et al. [@CR12]). Automated control of FiO~2~, discussed elsewhere in this text, offers the possibility of better targeting of SpO~2~ ranges and less hyperoxia (Claure et al. [@CR21]) but remains largely unavailable at present.

Frequent adjustments to FiO~2~ are required in many ventilated newborns, in particular those with episodes of frequent apnoea or chest splinting in expiration (Bolivar et al. [@CR12]). Prolonged periods of high FiO~2~ may be necessary in infants with very significant parenchymal disease, pulmonary hypertension or both. In general, every opportunity should be taken to reduce FiO~2~, both by choosing the lowest acceptable SpO~2~ target and by optimising lung volume and recruitment at every juncture.

Acceptable Oxygen Saturation in Premature Infants {#Sec17}
=================================================

Oxygen saturation monitoring has been a routine part of neonatal intensive care for several decades, but until recently there has been a dearth of information concerning the correct target ranges (upper and lower limits) for SpO~2~ in preterm infants receiving supplemental oxygen. In recent years, however, there has been an accumulation of clinical trial evidence regarding oxygen therapy and appropriate oxygen saturation targets in premature infants (STOP-ROP Multicenter Study Group [@CR94]; Askie et al. [@CR6]; Carlo et al. [@CR17]; Schmidt et al. [@CR500]; Stenson et al. [@CR501]; Stenson [@CR502]), overcoming at least in part a great deal of uncertainty (Tin and Wariyar [@CR100]). This information has been taken into account in formulating the recommendations for SpO~2~ target ranges indicated in Table [42.7](#Tab7){ref-type="table"}.Table 42.7Suggested target ranges for oxygen saturation*Preterm \< 28 weeks gestation at birth*Before 36 weeks CGA^a^90--94 %≥36 weeks CGA92--96 %*Preterm 28--36 weeks gestation at birth*Before 36 weeks CGA90--94 %≥36 weeks CGA92--96 %*Term*Parenchymal lung disease92--96 %Persistent pulmonary hypertension94--98 %^a^Cyanotic congenital heart disease70--85 %^b^*CGA* corrected gestational age^a^Appropriate pO~2~ target at least 50 mmHg^b^Where there is a duct-dependent pulmonary blood flow, supplemental oxygen may constrict or close the ductus arteriosus

What Is the Safe Upper Limit for SpO~2~ in the Preterm Infant? {#Sec18}
--------------------------------------------------------------

The association of hyperoxia with adverse pulmonary, neurological and retinal effects in the preterm infant is well understood and is discussed elsewhere in this book. In the era of saturation monitoring, relative hyperoxia (SpO~2~ ≥95 %) from 32 weeks corrected gestation or beyond has been associated with progression of chronic lung disease (STOP-ROP Multicenter Study Group [@CR94]; Askie et al. [@CR6]), without altering the outcome of retinopathy (STOP-ROP Multicenter Study Group [@CR94]). More recently, a number of clinical trials, conducted in the USA, Canada, UK, Australia and New Zealand, have compared target SpO~2~ ranges of 85--89 % and 91--95 % commenced soon after birth in preterm infants \<28 weeks gestation. These target ranges remained in force up until 36 weeks corrected gestation, as long as the infant is receiving supplemental oxygen. An initial report from each of these studies has now been published (Carlo et al. [@CR17]; Schmidt et al. [@CR500]; Stenson et al. [@CR501]), and an individual patient meta-analysis combining data from all trials (the NeOProM collaboration) is awaited (Stenson [@CR502]). Three methodological issues in these trials bear consideration. The first is that for both high (91--95 %) and low (85--89 %) target groups, the actual SpO~2~ readings when in supplemental oxygen were at the high end of the intended range, likely a reflection of a well-documented tendency for bedside staff to target the high end of an SpO~2~ range (Clucas et al. [@CR22]). Moreover, the upward shift in actual SpO~2~ readings was more prominent in the lower target group, with a median SpO~2~ value of around 90--91 %, and on average only a 3 % separation between readings in the two groups, rather than the 6 % that would have been expected. The second methodological consideration is that while the trials were being conducted, the SpO~2~ calibration curve within the oximeters being used was found to under-represent SpO~2~ values of 87--90 % (Stenson [@CR502]). Installation of a revised algorithm in the UK and Australian trials led in to a clearer separation in SpO~2~ readings between the groups, and appeared to affect the outcomes (see below). The final methodological issue is that in only one of the studies (the COT study, Schmidt et al. [@CR500]) were both upper and lower alarms limits clearly stipulated and enforced, which may have affected the proportion of extreme SpO~2~ values, and thus potentially the results.

Overall the findings of the recent clinical trials of SpO~2~ targeting were (a) that a lower target range (85--89 %) was associated with an increased risk of mortality (the exception being the COT study (Schmidt et al. [@CR500])), with the relative risk of in-hospital mortality being 1.3 to 1.4 (Carlo et al. [@CR17]; Stenson et al. [@CR501]); (b) that a lower target range also appeared to predispose to necrotising enterocolitis; and (c) that a higher target range (91--95 %) was associated with an increase in retinopathy of prematurity (relative risk 1.3--2.0) with again the COT study being the exception. The COT study investigators commented that strict enforcement of alarm limits, and in particular the upper limit, may have contributed to the lack of association between the high target group and retinopathy noted in their study.

The SpO~2~ targeting trials performed to date have not examined multiple SpO~2~ ranges, and thus recommendations about the safe upper and lower limits can only be based on the information at hand. Nevertheless, balancing the risks of mortality and necrotising enterocolitis on the one hand, against the risk of retinopathy on the other, an upper SpO~2~ limit of 94 % would seem prudent, with an alarm set at 96 % and active at all times when in supplemental oxygen (Table [42.7](#Tab7){ref-type="table"}). A higher upper limit (96 %) is appropriate for preterm infants beyond 36 weeks corrected gestation. The upper limit of 96 % can also be applied from the outset to term infants with parenchmal lung disease, in whom the risk of retinopathy is negligible. A higher target range (and thus upper limit) is recommended for infants with pulmonary hypertension (Table [42.7](#Tab7){ref-type="table"}).

What Is the Safe Lower Limit for SpO~2~ in the Preterm Infant? {#Sec19}
--------------------------------------------------------------

The combined results of the SpO~2~ targeting trials point to an increase in mortality and probably necrotising enterocolitis where an SpO~2~ below 90 % is targeted. For this reason, a lower SpO~2~ limit at or above 90 % has been recommended for preterm infants \<36 weeks corrected age (Table [42.7](#Tab7){ref-type="table"}). A lower SpO~2~ limit at or above 92 % is appropriate for term infants in most clinical contexts (Table [42.7](#Tab7){ref-type="table"}), with the exception being cyanotic congenital heart disease.

Safe CO~2~ Limits {#Sec20}
=================

There are good experimental data in support of the role of permissive hypercapnia in lung injury protection (as discussed elsewhere in this book). These effects go beyond the reduced minute ventilation that goes hand in hand with permissive hypercapnia; elevated FiCO~2~ appears to offer protection independent of minute ventilation (Peltekova et al. [@CR75]). The need for lower minute ventilation should in itself reduce lung injury in the preterm infant, although this hypothesis, whilst supported in a small single-centre trial (Mariani et al. [@CR64]), was not clearly validated in the large clinical trial conducted by the Neonatal Research Network (Carlo et al. [@CR16]).

The safe limits of PaCO~2~ are difficult to determine from available literature. Despite decades of use of mechanical ventilation of newborn infants, the number and quality of studies specifically addressing this critical question is surprisingly low. There is unequivocal evidence that low PaCO~2~ is associated with increased risk of severe intraventricular haemorrhage (IVH) and periventricular leukomalacia (Graziani et al. [@CR45]; Fujimoto et al. [@CR39]; Wiswell et al. [@CR111]; Okumura et al. [@CR73]; Collins et al. [@CR23]) and that very high levels, especially in preterm infants during the first few days of life, may also increase the risk of IVH (Kaiser et al. [@CR53]; Fabres et al. [@CR35]). The data of Fabres et al. indicated that even modestly decreased PaCO~2~ (\<39 mmHg) was associated with a twofold increase in IVH, as was a maximal PaCO~2~ over 60 mmHg and prolonged exposure to a PaCO~2~ greater than 52 mmHg. However, safe lower and upper limits remain an open question. The postnatal age of the infant, the degree of prematurity and coexisting morbidities, such as asphyxia, hypotension and sepsis, which are known to impair cerebral blood flow autoregulation, all affect the vulnerability of the patient to high or low levels of CO~2~. The studies showing association of hypercapnia and IVH focussed on the early postnatal period. The only large prospective clinical trial of permissive hypercapnia suggests safety of mild permissive hypercapnia, but the mean PaCO~2~ remained between 45 and 50 mmHg for the first 7 days of life in the "hypercapnia" group (Carlo et al. [@CR16]). This study does not, therefore, refute the retrospective data suggesting increased risk of adverse outcomes with maximal PaCO~2~ values above 60 mmHg during the first week of life (Fabres et al. [@CR35]). Whilst there are very plausible pathophysiological mechanisms which link hypercapnia to IVH, it must be recognised that the retrospective studies cannot establish causation. It is possible that high CO~2~ values are a marker for other events or a reflection of the severity of illness rather than the cause of the IVH. A relatively small prospective trial targeting PaCO~2~ values between 55 and 65 from birth enrolled only one-third of the projected sample size (65 infants) before being stopped early because target PCO~2~ values could not be reached (Thome et al. [@CR99]). This study found no difference in pulmonary outcomes but an increase in the composite outcome of death or neurological impairment at 18--22 months from 42 to 62 % in the hypercapnia group, despite a difference of only 6 mmHg in PaCO~2~ values between the groups.

Data on safety of permissive hypercapnia beyond the first week of life are lacking. It is generally believed that because of metabolic compensation and less vulnerability to IVH, higher levels of PaCO~2~ can be tolerated safely, but neither the validity of the assumption nor the safe upper limits of PaCO~2~ during this period have been established.

Although clinical studies have focussed on PaCO~2~, whether PaCO~2~ or pH should be our primary concern is still subject to debate; clinical studies have not specifically addressed the question of whether compensated respiratory acidosis is safe or whether the infant with metabolic acidosis compensated by hyperventilation is at similar risk as one who has an uncompensated alkalosis. Experimental studies clearly show, however, that local tissue pH, not pCO~2~, is the primary determinant of cerebral vasoconstriction or dilatation (Fencl et al. [@CR36]; Kontos et al. [@CR58]). Rapid changes in PaCO~2~ are also dangerous and should be avoided, because they lead to rapid changes in cerebral blood flow (Raichle et al. [@CR78]; Gleason et al. [@CR43]). A large retrospective study of 849 preterm infants concluded that not only both extremes of CO~2~ but also fluctuations in PaCO~2~ are associated with severe IVH (Fabres et al. [@CR35]).

What then is the clinician to do in the face of such uncertainty? First, it should be recognised that low PaCO~2~ values are clearly more dangerous than moderately high values and that targeting mildly hypercapnic values decreases the risk of inadvertent hypocapnia. Second, it is important to avoid rapid changes in PaCO~2~. On balance, available evidence suggests that keeping PaCO~2~ values in the range of 45--50 mmHg during the first week of life is appropriate and safe. As a practical matter, because very preterm infants have a low renal threshold for bicarbonate and tend to have a modest metabolic acidosis, it is difficult to achieve significant hypercapnia during the first few days of life without unacceptable degree of acidosis. With time, the vulnerability of the brain to IVH decreases, and metabolic compensation develops, allowing PaCO~2~ to rise to levels of 50--60 mmHg with relatively normal pH by the second and third week of life. Permissive hypercapnia with PaCO~2~ values of 60--70 mmHg is widely practised and not clearly associated with adverse outcomes. The safety of this approach is in need of urgent study.

Essentials to Remember {#d29e3369}
----------------------

Ventilator settings in the neonate should be individualised, taking into account the context in which respiratory failure has occurred, the effects on lung volume and compliance and the vulnerability of the lung to injury.Where possible, ventilation should be in synchrony with spontaneous respiratory effort.PEEP is the most important determinant of end-expiratory lung volume and oxygenation.Delivery of each tidal breath is important not only for gas exchange but also recruitment.Premature neonates are more vulnerable to oxygen toxicity, and the target SpO~2~ range in these infants is thus lower than for term infants.Hypocapnia is significantly more dangerous than hypercapnia in ventilated neonates.
